BioSpace News Archive

Press Releases

FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting

April 30, 2025
·
1 min read
Press Releases

Better Choice Company Completes Name Change to SRx Health Solutions Inc. and Begins Trading Under the Ticker Symbol ‘SRXH’ Today, Wednesday, April 30, 2025

April 30, 2025
·
2 min read
Press Releases

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)

April 30, 2025
·
20 min read
Press Releases

Medicenna Presents Promising Preclinical Data from its First-in-Class Tumor Targeted and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the Annual 2025 AACR Meeting

April 30, 2025
·
7 min read
Press Releases

SpectronRx Announces Positive FDA Assessment of its Indianapolis, Indiana Facility

April 30, 2025
·
2 min read
Press Releases

Curi Bio and Cook MyoSite Announce Strategic Partnership

April 30, 2025
·
3 min read
Press Releases

Glaukos Announces First Quarter 2025 Financial Results

April 30, 2025
·
15 min read
Press Releases

LENZ Therapeutics to Report First Quarter 2025 Financial Results and Recent Corporate Highlights on May 7th, 2025

April 30, 2025
·
1 min read
Press Releases

Ultragenyx to Host Conference Call for First Quarter 2025 Financial Results and Corporate Update

April 30, 2025
·
1 min read
Press Releases

ESSENCE phase 3 trial of semaglutide showed significant improvements at 72 weeks in adults with MASH, published in NEJM

April 30, 2025
·
10 min read